New York, NY (April 30, 2010) – At D.R.E.a.M.S. in the City, which benefits the Diabetes Research Institute, hundreds of New York’s trendsetters, socialites and industry leaders, like the acclaimed Chef Michel Nischan and Bob DeRoose, president and CEO of wine and spirits giant Kobrand Corporation, will enjoy an evening of grandeur on Thursday, May 6, 2010 at 6:30 p.m. at Capitale, located at 130 Bowery. Nischan and DeRoose will also serve as the evening’s honorees.
Joining the revelry will be New York Giants Gerris Wilkinson, Chris Canty, Mario Manningham, Adam Koets and Rocky Bernard, plus rising singing star Shontelle, celebrity stylist Philip Bloch, TV’s Dr. Max Gomez and the evening’s emcee Alan Kalter of the Late Show with David Letterman.
According to Chairs Samantha Shanken Baker and Bonnie Inserra, new and returning guests alike will be “wow-ed” with this year’s innovative offerings, courtesy of Wine Spectator and Kobrand. Guaranteed to impress the most discerning palates, there will be a station for connoisseurs of all sorts: a Wine Bar, A Champagne and Sparkling Wine Bar, and a Cocktail and Beer Bar with specialty drinks, such as the Appleton-Ting, which will introduce imbibers to a very hard-to-find Jamaican favorite.
Not to be missed and possibly the most anticipated will be the Dessert Bar, which pairs the perfect wine or spirit with a selection of decadent after-dinner fare in miniature sizes. (Note to guests – take more than one!)
Also on tap that evening will be a seated dinner, fabulous live and silent auctions, live music and more.
Tickets to D.R.E.a.M.S. in the City are $400 per person and $200 per person for junior guests (under 35). Tickets can be purchased by calling the Diabetes Research Institute Foundation at 212-888-2217. Visit DiabetesResearch.org for more information or email firstname.lastname@example.org.
The Diabetes Research Institute, a center of excellence at the University of Miami Miller School of Medicine, is a recognized world leader in cure-focused research. Since its inception in the early 1970s, the DRI has made significant contributions to the field of diabetes research, pioneering many of the techniques used in islet transplantation. The DRI is now building upon these achievements by bridging cell-based therapies with emerging technologies to restore insulin production. For the millions of families already affected by diabetes, the Diabetes Research Institute is the best hope for a cure.